IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 563 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1609    
    Printed82    
    Emailed2    
    PDF Downloaded247    
    Comments [Add]    

Recommend this journal

 

 RESEARCH PAPER
Year : 1994  |  Volume : 26  |  Issue : 2  |  Page : 112-116

Double blind randomized clinical trial of cetirizine in the treatment of Perennial allergic rhintis



Correspondence Address:
S Rajaram


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

The efficacy and tolerability of cetirizine, a second generation H1 receptor blocker, was evaluated in perennial allergic rhinitis patients. Fifty-one of them, took part in a double blind randomized study during which they were treated for 4 weeks with either cetirizine 10 mg (n=17) or astemizole 10 mg (n=18) or placebo (n=16) with once daily oral dose. Nine patients were excluded from the trial due to non-compliance or protocol violation. Our study revealed that cetirizine alleviated almost all the symptoms of perennial allergic rhinitis viz., sneezing, rhinorrhoea, nasal obstruction and nasal pruritus. Cetirizine and astemizole did not differ significantly in either efficacy or toleration, though both had efficacy superior to placebo. Cetirizine may be a useful antihistamine in the treatment of perennial allergic rhinitis for its long action, non-sedative property and convenient dosing schedule.






[PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow